Attached files
| file | filename |
|---|---|
| EX-32.1 - EXHIBIT 32.1 - ACELRX PHARMACEUTICALS INC | ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - ACELRX PHARMACEUTICALS INC | ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - ACELRX PHARMACEUTICALS INC | ex31-1.htm |
| EX-23.1 - EXHIBIT 23.1 - ACELRX PHARMACEUTICALS INC | ex23-1.htm |
| EX-21.2 - EXHIBIT 21.2 - ACELRX PHARMACEUTICALS INC | ex21-2.htm |
| EX-10.43 - EXHIBIT 10.43 - ACELRX PHARMACEUTICALS INC | ex10-43.htm |
| 10-K - FORM 10-K - ACELRX PHARMACEUTICALS INC | acrx20161231_10k.htm |
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in the Registration Statements:
(1) Registration Statements on Form S-8 Nos. 333-209998, 333-202709, 333-194634, 333-187206 and 333-180334 pertaining to the 2011 Equity Incentive Plan of AcelRx Pharmaceuticals, Inc.,
(2) Registration Statements on Form S-8 Nos. 333-209998 and 333-180334 pertaining to the 2011 Equity Incentive Plan and 2011 Employee Stock Purchase Plan of AcelRx Pharmaceuticals, Inc.,
(3) Registration Statement on Form S-8 No. 333-172409 pertaining to the 2006 Stock Plan, 2011 Equity Incentive Plan and 2011 Employee Stock Purchase Plan of AcelRx Pharmaceuticals, Inc., and
(4) Registration Statements Form S-3 No. 333-196089, 333-190003, 333-183237, 333-182245 of AcelRx Pharmaceuticals, Inc. and in the related prospectuses;
of our report dated March 12, 2015, except for Note 1 and 7, as to which the date is March 7, 2016, with respect to the consolidated financial statements of AcelRx Pharmaceuticals, Inc., included in this Annual Report on Form 10-K of AcelRx Pharmaceuticals, Inc. for the year ended December 31, 2016.
/s/ Ernst & Young LLP
Redwood City, California
March 2, 2017